|Other Accession||NM_001098525, NP_001091995|
|Reactivity||Human, Rat, Rabbit, Horse, Bovine, Guinea Pig, Dog|
|Predicted||Human, Pig, Horse, Bovine, Dog|
|Alias Symbol||DKFZp686L1238, FLJ10749, LB1, TMAP, se20-10|
|Other Names||Cytoskeleton-associated protein 2, CTCL tumor antigen se20-10, Tumor- and microtubule-associated protein, CKAP2 (HGNC:1990)|
|Format||Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.|
|Reconstitution & Storage||Add 50 ul of distilled water. Final anti-CKAP2 antibody concentration is 1 mg/ml in PBS buffer with 2% sucrose. For longer periods of storage, store at 20°C. Avoid repeat freeze-thaw cycles.|
|Precautions||CKAP2 antibody - C-terminal region is for research use only and not for use in diagnostic or therapeutic procedures.|
|Function||Possesses microtubule stabilizing properties. Involved in regulating aneuploidy, cell cycling, and cell death in a p53/TP53-dependent manner (By similarity).|
|Cellular Location||Cytoplasm, cytoskeleton. Cytoplasm, cytoskeleton, spindle. Cytoplasm, cytoskeleton, spindle pole Note=Contrary to the ectopically expressed protein, endogenous CKAP2 does not colocalize with microtubules in G1, S and early G2 At late G2 and prophase after separation of duplicated centrosomes, colocalizes with gamma-tubulin and centrosome- proximal microtubules. From prometaphase through anaphase B, colocalizes with mitotic spindle poles and spindle microtubules During cytokinesis, absent from midbody microtubules|
|Tissue Location||Abundant in testis, thymus, and in tumor derived cell lines, while barely detectable in liver, prostate, and kidney.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abgent to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Maouche-Chretien L.,et al.Oncogene 17:1245-1251(1998).
Udina I.G.,et al.Genetika 37:120-123(2001).
Bae C.-D.,et al.J. Cancer Res. Clin. Oncol. 129:621-630(2003).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Bechtel S.,et al.BMC Genomics 8:399-399(2007).
If you have used an Abgent product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.